Login / Signup

Safety and Efficacy of Intensive Blood Pressure-Lowering After Successful Endovascular Therapy in AIS: A Meta-Analysis.

Zhouzan LiaoLi TianMing WenBing WangKai DingQionglin Song
Published in: The neurologist (2024)
Based on the current evidence, intensive blood pressure-lowering regimen was superior to standard blood pressure-lowering regimen for a reduced risk of symptomatic intraparenchymal hemorrhage in AIS patients treated with EVT, but there was no statistically significant difference found between the 2 regimens for the other outcomes.
Keyphrases
  • blood pressure
  • hypertensive patients
  • heart rate
  • blood glucose
  • stem cells
  • type diabetes
  • adipose tissue
  • mesenchymal stem cells
  • bone marrow
  • cell therapy
  • weight loss
  • replacement therapy